IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma

Isabell Hentschke1, Anna Graser1, Volker O Melichar2

  • 1Abteilung für Molekulare Pneumologie, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Scientific Reports
|March 7, 2017
PubMed

Insights

In preschool children, Gram-negative bacteria in the nose correlate with higher interferon beta (IFNβ) and IL-33 levels. Antibiotic treatment impacts immune responses, particularly in asthmatic children.

Area of Science:

  • Pediatric immunology
  • Microbial-immune interactions

Background:

  • Asthma is linked to altered immune responses and susceptibility to infections.
  • Nasopharyngeal bacterial colonization plays a role in respiratory health.

Purpose of the Study:

  • To investigate the relationship between bacterial colonization and immune responses in preschool asthmatic children.
  • To assess the impact of antibiotic therapy on these interactions.

Main Methods:

  • Analysis of nasopharyngeal fluids (NPF) and blood samples from asthmatic and control children.
  • Measurement of cytokine levels (IFNβ, IL-33) and immune markers (ST2).
  • Correlation of bacterial presence with immune parameters and infection history.

Main Results:

  • Gram-negative bacteria (Haemophilus influenzae, Moraxella catarrhalis) associated with higher IFNβ and IL-33 in asthmatic children's NPF.
  • Gram-positive bacteria co-colonization induced IL33R-ST2 in asthmatic children's blood.
  • Antibiotic treatment reduced ST2 and IL-33 levels, with varying effects based on bacterial presence and asthma status.

Conclusions:

  • Gram-negative bacteria contribute to local IL-33 in asthmatic children, persisting post-antibiotics.
  • Gram-positive bacteria, especially without Staphylococcus aureus, influence IFN-β and ST2 responses differently in asthmatics versus controls.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K